DISPOSITION AND METABOLISM OF ADRIAMYCIN OCTANOYLHYDRAZONE (NSC-233853) IN MICE AND RABBITS
- 1 January 1981
- journal article
- research article
- Vol. 9 (3) , 240-245
Abstract
The disposition, metabolism and excretion of adriamycin octanoylhydrazone (OctAdr) were studied after i.v. administration to BALB/c mice and New Zealand White rabbits and were compared to similar studies of adriamycin (Adr). In mice, concentrations of OctAdr-derived fluorescence were initially greatest in lung with very low concentrations detectable in kidney, liver and spleen. Little drug fluorescence was found in brain, heart or skeletal muscle. Adriamycin had the highest drug fluorescence concentration in the kidney, with progressively lower but easily detectable concentrations in liver, heart, lung, spleen and skeletal muscle. Drug fluorescence was lost much more rapidly from tissues of mice injected with OctAdr than from tissues of mice injected with Adr. At all times after injection, Adr was the major fluorescent drug species recovered from livers and kidneys of mice treated with OctAdr or Adr, although substantial amounts of unaltered OctAdr were recovered from the former group. In rabbits, plasma concentrations of OctAdr-derived fluorescence declined rapidly but then remained relatively constant from 120 to 480 min after injection. No OctAdr-derived fluorescence was observed in urine. During the 8 h after injection, biliary excretion of OctAdr represented approximately 25% of the administered dose. At all times after injection, OctAdr was the major biliary fluorescent species, with Adr and adriamycinol (Adrol) the 2nd and 3rd most prominent, respectively. Eight hours after OctAdr administration, lung contained the highest concentration of drug-related fluorescence, with progressively lower amounts in liver, kidney, duodenum and heart. Brain, skeletal muscle and spleen contained little or no OctAdr-derived fluorescence. Adr and OctAdr were the major fluorescent species in all tissues. Small amounts of Adrol was detected in all tissues, but aglycones were present only in liver.This publication has 17 references indexed in Scilit:
- Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac CatheterizationAnnals of Internal Medicine, 1978
- Rat liver aldehyde reductaseBiochemical Pharmacology, 1977
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassayClinical Pharmacology & Therapeutics, 1977
- PLASMA PHARMACOKINETICS OF ADRIAMYCIN AND ITS METABOLITES IN HUMANS WITH NORMAL HEPATIC AND RENAL-FUNCTION1977
- ANTI-TUMOR ACTIVITY OF NEW ANTHRACYCLINE ANTIBIOTICS, ACLACINOMYCIN-A AND ITS ANALOGS, AND THEIR TOXICITY1977
- Rubidazone vs adriamycin: An evaluation of their differential toxicity in the spleen colony assay systemBritish Journal of Cancer, 1976
- Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignanciesCancer, 1976
- MICROSOMAL REDUCTIVE GLYCOSIDASE1976
- AdriamycinAnnals of Internal Medicine, 1974